Atopic dermatitis therapy breakthrough on the horizon?

Occlusive Therapy in Atopic Dermatitis

Misha M. Heller1, Eric S. Lee2, Faranak Kamangar3, Wilson Liao4 and John Y. M. Koo4 1University of Southern California, Keck School of Medicine, Los Angeles, California 2University of Nebraska Medical Center, College of Medicine, Omaha, Nebraska 3University of California Davis, School of Medicine, Sacramento, California 4University of California San Francisco, Department of Dermatology San Fran...

Atopic dermatitis: phototherapy and systemic therapy.

The majority of atopic dermatitis (AD) patients respond satisfactorily to gentle bathing, frequent moisturizing, and topical medications. Second-line therapies for AD should be used in recalcitrant cases or in patients with uncontrolled disease despite compliance with first-line measures and avoidance of allergens. Recommended advanced therapies include phototherapy, especially narrowband ultra...

Guideline on the Treatment of Atopic Eczema (Atopic Dermatitis)

Subcommittee Members: Prof. Dr. Johannes Ring, Munich (Germany) Mr. Thomas Schwennesen, Hamburg (Germany) Prof. Dr. Agustín Alomar, Barcelona (Spain) Prof. Dr. Stefania Seidenari, Modena (Italy) Prof. Dr. Thomas Bieber, Bonn (Germany) Prof. Dr. Dagmar Simon, Bern (Switzerland) Dr. Mette Deleuran, Aarhus (Denmark) Prof. Dr. Sonja Ständer, Münster (Germany) Dr. Antje-H. Fink-Wagner, Konstanz (Ger...

Update on Epidemiology, Diagnosis, and Disease Course of Atopic Dermatitis Review of Critical Issues in the Pathogenesis of Atopic Dermatitis Assessing the New and Emerging Treatments for Atopic Dermatitis The Changing Paradigm of Atopic Dermatitis Therapy

A short review on immunology of Atopic dermatitis

Atopic dermatitis (AD) is a pruritic, relapsing, chronic disease that arises most commonly during infancy, childhood, or adolescence. It is clear that genetic factors are important in AD, a family history of AD, allergic rhinitis, and/or asthma and other “Atopic” phenomena being common in patient with AD. The two main pathogenetic characteristic of AD are: I) IgE-mediated antigen dependent “Spe...